Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
June 11, 2012
6/13/2012
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities...
June 4, 2012
6/6/2012
Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to...
June 4, 2012
Royer Biomedical Receives Approval to Test Polymer Delivery System
Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to proceed with human testing of AppliGel-G (Gentamicin) in management...
May 28, 2012
5/30/2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd....
May 28, 2012
Bend Research Increases Hot-Melt Extrusion Capacity
Bend Research Inc. recently announced the expansion of its existing hot-melt extrusion (HME) capacity with the addition of an 18-mm...
May 20, 2012
5/23/2012
Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently...
May 14, 2012
5/16/2012
Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...
May 6, 2012
5/9/2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
May 6, 2012
Midatech & MonoSol Rx Announce Positive Results for Transbuccal Oral Insulin Film
Midatech Ltd. and MonoSol Rx LLC recently announced positive bioavailability and pharmacokinetic results from a first-in-human Phase I clinical study...
May 6, 2012
Prosonix Demonstrates Improved Delivery & Co-Localization of Respiratory Medicines
Prosonix recently announced the publication of a new review paper describing how its novel particle-engineering-led approach to respiratory medicines is...
